![Safa'a Al-Rais](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Safa'a Al-Rais
Direttore operativo presso Resilience Biotechnologies, Inc.
Posizioni attive di Safa'a Al-Rais
Società | Posizione | Inizio | Fine |
---|---|---|---|
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Direttore operativo | - | - |
Storia della carriera di Safa'a Al-Rais
Precedenti posizioni note di Safa'a Al-Rais
Società | Posizione | Inizio | Fine |
---|---|---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Direttore operativo | 01/05/2009 | 01/10/2020 |
Statistiche
Distribuzione geografica
Canada | 3 |
Posizioni
Chief Operating Officer | 2 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |
- Borsa valori
- Insiders
- Safa'a Al-Rais
- Esperienza